Skip to main content
Log in

Sophocarpine suppress inflammatory response in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis

  • Research Article
  • Published:
European Cytokine Network Aims and scope

Abstract

Background

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting nearly 1% of adults worldwide. This study aimed to investigate whether sophocarpine is a potential drug for treating RA.

Methods

The cytotoxicity of sophocarpine to RA-fibroblast-like synoviocytes (FLSs) was evaluated using 3-[4,-dimethylthiazol-2-y]-2,5-diphenyl-tetrazolium bromide (MTT) assays kit and released lactate dehydrogenase (LDH) assays. The transcription of proinflammatory cytokines in RA-FLSs was analyzed by reverse transcription and real-time polymerase chain reaction (RT-PCR). The proteins levels were further verified by enzyme-linked immunosorbent assay (ELISA). The alterations in the mediators of mitogen-activated protein kinase (MAPK) and nuclear factor κB (NF-κB) signaling pathways were tested by western blotting. The clinical effects of sophocarpine were evaluated in type II collagen-induced arthritis (CIA) in DBA-/1 mouse model by scoring their clinical responses, synovitis, and cartilage destructions, and ELISA was employed to analyze the concentrations of proinflammatory cytokines in the serum of CIA mice.

Results

The results showed that sophocarpine contained low cytotoxicity to RA-FLS cells, and it was capable to downregulate the expressions of LPS-induced proinflammatory cytokines. The suppressions of MAPK and NF-κB signaling pathways by sophocarpine were also found in LPS-induced RA-FLSs. The attenuation of the symptoms in CIA mouse model were significant, in which concentrations of proinflammatory cytokines were decreased after the sophocarpine treatment.

Conclusion

In this study, we demonstrated the potential of sophocarpine in treating RA, both in vitro and in vivo. Sophocarpine may be a potential drug in treating human RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356–61.

    Article  CAS  PubMed  Google Scholar 

  2. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429–42.

    Article  CAS  PubMed  Google Scholar 

  3. van der Heijden JW, Dijkmans BA, Scheper RJ, Jansen G. Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs–from bench to bedside. Nat Clin Pract Rheumatol 2007; 3: 26–34.

    Article  PubMed  Google Scholar 

  4. Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2003; 2: 473–88.

    Article  CAS  PubMed  Google Scholar 

  5. O’Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004; 350: 2591–602.

    Article  PubMed  Google Scholar 

  6. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the best study): a randomized, controlled trial. Arthritis Rheum 2005; 52: 3381–90.

    Article  CAS  PubMed  Google Scholar 

  7. Smolen JS, Aletaha D. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat Rev Rheumatol 2015; 11: 276–89.

    Article  PubMed  Google Scholar 

  8. Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 2008; 47: 409–14.

    Article  CAS  Google Scholar 

  9. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 669–75.

    Article  CAS  Google Scholar 

  10. Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 2013; 9: 24–33.

    Article  CAS  PubMed  Google Scholar 

  11. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010; 233: 233–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lin Z, Huang CF, Liu XS, Jiang J. In vitro anti-tumour activities of quinolizidine alkaloids derived from Sophora flavescens Ait. Basic Clin Pharmacol Toxicol 2011; 108: 304–9.

    Article  CAS  PubMed  Google Scholar 

  13. Gao Y, Li G, Li C, et al. Anti-nociceptive and anti-inflammatory activity of sophocarpine. J Ethnopharmacol 2009; 125: 324–9.

    Article  CAS  PubMed  Google Scholar 

  14. Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J. Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol 2008; 8: 1767–72.

    Article  CAS  PubMed  Google Scholar 

  15. Gao Y, Jiang W, Dong C, et al. Anti-inflammatory effects of sophocarpine in LPS-induced RAW 264.7 cells via NF-kappaB and MAPKs signaling pathways. Toxicol In Vitro 2012; 26: 1–6.

    Article  PubMed  Google Scholar 

  16. Zhang JM, Zhu YB, Deng X, Wang CX, Luan SM, Chen YX. Mechanism of sophocarpine in treating experimental colitis in mice. Zhongguo Zhong Yao Za Zhi 2015; 40: 3081–7.

    CAS  PubMed  Google Scholar 

  17. Li J, Li L, Chu H, Sun X, Ge Z. Oral sophocarpine protects rat heart against pressure overload-induced cardiac fibrosis. Pharm Biol 2014; 52: 1045–51.

    Article  CAS  PubMed  Google Scholar 

  18. Song CY, Zeng X, Chen SW, et al. Sophocarpine alleviates non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 2011; 26: 765–74.

    Article  CAS  PubMed  Google Scholar 

  19. Song CY, Zeng X, Wang Y, et al. Sophocarpine attenuates tolllike receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis. J Gastroenterol Hepatol 2015; 30: 405–12.

    Article  CAS  PubMed  Google Scholar 

  20. Wang D, Xu N, Zhang Z, et al. Sophocarpine displays antiinflammatory effect via inhibiting TLR4 and TLR4 downstream pathways on LPS-induced mastitis in the mammary gland of mice. Int Immunopharmacol 2016; 35: 111–8.

    Article  PubMed  Google Scholar 

  21. Wang XJ, Deng HZ, Jiang B, Yao H. The natural plant product sophocarpine ameliorates dextran sodium sulfate-induced colitis in mice by regulating cytokine balance. Int J Colorectal Dis 2012; 27: 575–81.

    Article  PubMed  Google Scholar 

  22. Cameron M, Gagnier JJ, Little CV, Parsons TJ, Blumle A, Chrubasik S. Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part 2: rheumatoid arthritis. Phytother Res 2009; 23: 1647–62.

    Article  PubMed  Google Scholar 

  23. Li G, Liu D, Zhang Y, et al. Celastrol inhibits lipopolysaccharidestimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-kappaB-mediated matrix metalloproteinase-9 expression. PLoS One 2013; 8: e68905.

    Article  Google Scholar 

  24. Jin XN, Yan EZ, Wang HM, et al. Hyperoside exerts antiinflammatory and anti-arthritic effects in LPS-stimulated human fibroblast-like synoviocytes in vitro and in mice with collageninduced arthritis. Acta Pharmacol Sin 2016; 37: 674–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Xin W, Huang C, Zhang X, et al. Methyl salicylate lactoside inhibits inflammatory response of fibroblast-like synoviocytes and joint destruction in collagen-induced arthritis in mice. Br J Pharmacol 2014; 171: 3526–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Niu Y, Dong Q, Li R. Matrine regulates Th1/Th2 cytokine responses in rheumatoid arthritis by attenuating the NF-KappaB signaling. Cell Biol Int 2017; 41: 611–21.

    Article  CAS  PubMed  Google Scholar 

  27. Pu J, Fang FF, Li XQ, et al. Matrine exerts a strong anti-arthritic effect on type II collagen-induced arthritis in rats by inhibiting inflammatory responses. Int J Mol Sci 2016: 17.

    Google Scholar 

  28. Chen SX, Mei SW, Wang PQ. Therapeutic effect of kangke injection on viral myocarditis and its anticoxsackie virus mechanism. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997; 17: 207–9.

    CAS  PubMed  Google Scholar 

  29. Meyer LH, Franssen L, Pap T. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis. Best Pract Res Clin Rheumatol 2006; 20: 969–81.

    Article  CAS  PubMed  Google Scholar 

  30. Schett G, Tohidast-Akrad M, Smolen JS, et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 2000; 43: 2501–12.

    Article  CAS  PubMed  Google Scholar 

  31. Koch AE. Chemokines and their receptors in rheumatoid arthritis: future targets? Arthritis Rheum 2005; 52: 710–21.

    Article  PubMed  Google Scholar 

  32. Gerlag DM, Ransone L, Tak PP, et al. The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collageninduced arthritis. J Immunol 2000; 165: 1652–8.

    Article  CAS  PubMed  Google Scholar 

  33. Simmonds RE, Foxwell BM. Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 2008; 47: 584–90.

    Article  CAS  Google Scholar 

  34. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc 2007; 2: 1269–75.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liyan Zhu.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, L., Zhu, L. Sophocarpine suppress inflammatory response in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis. Eur Cytokine Netw 28, 120–126 (2017). https://doi.org/10.1684/ecn.2017.0400

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ecn.2017.0400

Key words

Navigation